Search

Bruce Zelus Phones & Addresses

  • Panama City, FL
  • 1433 S Ward St, Lakewood, CO 80228 (303) 763-9680
  • Denver, CO
  • Madison, WI
  • Seattle, WA
  • Hammond, IN

Work

Company: Viawest Aug 2010 Position: Senior database administrator

Education

Degree: PhD School / High School: University of Washington School of Medicine 1986 to 1991 Specialities: Pharmacology

Skills

Data Center • Disaster Recovery • System Deployment • Servers • Virtualization • Managed Services • Vmware • High Availability • Windows Server • Linux • Troubleshooting • System Administration • Microsoft Sql Server • Mysql • Databases • Database Design

Ranks

Certificate: Mcsa: Sql Server 2012

Industries

Information Technology And Services

Resumes

Resumes

Bruce Zelus Photo 1

Aquatic Activities Coordinator

View page
Location:
1433 south Ward St, Lakewood, CO 80228
Industry:
Information Technology And Services
Work:
ViaWest since Aug 2010
Senior Database Administrator

ViaWest Feb 2007 - Aug 2010
Database Administrator

ViaWest Feb 2005 - Aug 2007
Network Operations Center - Solutions Engineer

VeriCenter Dec 2003 - Feb 2005
Datacenter Analyst (Site Lead)

Sprint Oct 2001 - Dec 2003
Internet Center Deployment Analyst
Education:
University of Washington School of Medicine 1986 - 1991
PhD, Pharmacology
University of California, San Diego 1979 - 1984
BA, Organic Chemistry
Skills:
Data Center
Disaster Recovery
System Deployment
Servers
Virtualization
Managed Services
Vmware
High Availability
Windows Server
Linux
Troubleshooting
System Administration
Microsoft Sql Server
Mysql
Databases
Database Design
Certifications:
Mcsa: Sql Server 2012
Mcitp: Database Administrator 2008
Microsoft

Publications

Us Patents

Carcinoembryonic Antigen Cell Adhesion Molecule 1 (Ceacam1) Structure And Uses Thereof In Drug Identification And Screening

View page
US Patent:
20030211477, Nov 13, 2003
Filed:
May 1, 2002
Appl. No.:
10/138176
Inventors:
Kathryn Holmes - Golden CO, US
Bruce Zelus - Lakewood CO, US
Kemin Tan - Waltham MA, US
Jia-Huai Wang - Belmont MA, US
Rob Meijers - Sommerville MA, US
International Classification:
C12Q001/70
C12Q001/68
C07K002/00
C07K004/00
C07K005/00
C07K007/00
C07K014/00
C07K016/00
C07K017/00
A61K038/00
C07K001/00
US Classification:
435/006000, 435/005000, 530/300000, 530/350000
Abstract:
Disclosed is the first crystal structure in the carcinoembryonic antigen (CEA) family, the mouse CEACAM1a[1,4], containing the N-terminal functional domain that is characterized as having a uniquely folded CC′ loop. This novel feature could not be predicted based on sequence analysis alone. The structure has provided a prototypic architecture for modeling human homologues within the CEA family. These tertiary structures are used in a number of screening methods for identifying candidate molecules that have a binding affinity for the tertiary structure of the CC′ loop and its vicinity. Pharmaceutical preparations that include one or more of such identified candidates may then be provided and used in treatments for certain bacterial and viral infections, certain tumors and disorders of angiogenesis or immune responses and autoimmune disease.

Carcinoembryonic Antigen Cell Adhesion Molecule 1 (Ceacam1) Structure And Uses Thereof In Drug Identification And Screening

View page
US Patent:
20030190600, Oct 9, 2003
Filed:
Apr 5, 2002
Appl. No.:
10/118471
Inventors:
Kathryn Holmes - Golden CO, US
Bruce Zelus - Lakewood CO, US
Kemin Tan - Waltham MA, US
Jia-Huai Wang - Belmont MA, US
Rob Meijers - Somerville MA, US
International Classification:
A01N037/18
A61K038/00
C12Q001/70
G01N033/53
C07K001/00
C07K014/00
C07K017/00
US Classification:
435/005000, 435/007100, 530/350000, 514/002000
Abstract:
Disclosed are novel crystal structures of a carcinoembryonic cell adhesion antigen functional domain that is characterized as having a unique N-terminal domain structure, called a CC′ loop. This tertiary structure is used in a number of screening methods for identifying candidate molecules that have a binding affinity for the tertiary structure of the CC′ loop. Pharmaceutical preparations that include one or more of such identified candidate may then be provided and used in treatments for bacterial infections, dysentery, angiogenesis, immune cell mediated disease, and related conditions thereto.
Bruce D Zelus from Panama City, FL, age ~63 Get Report